Ionis Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of…

Biotechnology
US, Carlsbad [HQ]
Government, Law & Regulation

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Ionis Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Ionis Pharmaceuticals, Inc. can't present spending by time.

Contract Analysis

There are no contract award details available for Ionis Pharmaceuticals, Inc.

End of IONS's Analysis
CIK: 874015 CUSIP: 462222100 ISIN: US4622221004 LEI: - UEI: -
Secondary Listings
IONS has no secondary listings inside our databases.